Autoimmune Diseases  >>  Neulasta (pegfilgrastim)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neulasta (pegfilgrastim) / Roche
NCT00662519: Neulasta in Type 1 Diabetes

Completed
1
21
US
Neulasta (Pegylated), Pegylated granulocyte colony stimulating factor (GCSF), Placebo, Saline, Mixed Meal Tolerance Test (MMTT), Blood test, Hemoglobin A1C (HbA1c), DNA Test, Human Leukocyte Antigen (HLA)
University of Florida, Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
03/14
03/14

Download Options